{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T02:16:23Z","timestamp":1773972983398,"version":"3.50.1"},"reference-count":31,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T00:00:00Z","timestamp":1768867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009053","name":"Wellcome Trust DBT India Alliance","doi-asserted-by":"publisher","award":["IA\/CPHI\/18\/1\/503927"],"award-info":[{"award-number":["IA\/CPHI\/18\/1\/503927"]}],"id":[{"id":"10.13039\/501100009053","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Archives of Oral Biology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/j.archoralbio.2026.106512","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:09:16Z","timestamp":1767917356000},"page":"106512","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["HOXD10 expression in oral cancer is driven by histone acetylation rather than promoter DNA methylation"],"prefix":"10.1016","volume":"183","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7731-0304","authenticated-orcid":false,"given":"Dhanraj Salur","family":"Basavarajappa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"U Sangeetha","family":"Shenoy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveena Kumar","family":"AN","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shama Prasada","family":"Kabekkodu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjiban","family":"Chakrabarty","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0088-4777","authenticated-orcid":false,"given":"Raghu","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.archoralbio.2026.106512_bib1","first-page":"229","article-title":"Global cancer statistics 2022: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"74","author":"Bray","year":"2024","journal-title":"CA: A Cancer Journal for Clinicians"},{"issue":"February","key":"10.1016\/j.archoralbio.2026.106512_bib2","first-page":"347","volume":"6","author":"Califano","year":"2000","journal-title":"Genetic Progression and Clonal Relationship of Recurrent Premalignant Head and Neck Lesions"},{"issue":"7","key":"10.1016\/j.archoralbio.2026.106512_bib3","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.21037\/tcr-21-373","article-title":"Prognostic and clinical significance of HOXC9 and HOXD10 in papillary thyroid cancer","volume":"10","author":"Cao","year":"2021","journal-title":"Translational Cancer Research"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib4","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/ars.2014.5863","article-title":"Mechanisms of histone deacetylase inhibitor-regulated gene expression in cancer cells","volume":"23","author":"Chueh","year":"2015","journal-title":"Antioxidants Redox Signaling"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/cancers9010009","article-title":"Epigenomic regulation of androgen receptor signaling: Potential role in prostate cancer therapy","volume":"9","author":"Cucchiara","year":"2017","journal-title":"Cancers"},{"issue":"D1","key":"10.1016\/j.archoralbio.2026.106512_bib6","doi-asserted-by":"crossref","first-page":"D51","DOI":"10.1093\/nar\/gkw1069","article-title":"The eukaryotic promoter database in its 30th year: Focus on non-vertebrate organisms","volume":"45","author":"Dreos","year":"2017","journal-title":"Nucleic Aci Research"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-95845-3","article-title":"Evaluation of acetylation and methylation in oral rinse of patients with head and neck cancer history exposed to valproic acid","volume":"11","author":"Gama","year":"2021","journal-title":"Scientific Reports"},{"key":"10.1016\/j.archoralbio.2026.106512_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s40364-018-0122-2","article-title":"Epigenetic regulation of cancer progression by EZH2: From biological insights to therapeutic potential","volume":"6","author":"Gan","year":"2018","journal-title":"Biomarker Research"},{"key":"10.1016\/j.archoralbio.2026.106512_bib9","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13148-017-0412-9","article-title":"Silencing HOXD10 by promoter region hypermethylation activates ERK signaling in hepatocellular carcinoma","volume":"9","author":"Guo","year":"2017","journal-title":"Clinical Epigenetics"},{"issue":"4","key":"10.1016\/j.archoralbio.2026.106512_bib10","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1038\/bjc.2014.372","article-title":"The roles of HOXD10 in the development and progression of head and neck squamous cell carcinoma (HNSCC)","volume":"111","author":"Hakami","year":"2014","journal-title":"British Journal of Cancer"},{"issue":"2","key":"10.1016\/j.archoralbio.2026.106512_bib11","doi-asserted-by":"crossref","DOI":"10.3892\/or.2024.8861","article-title":"Epigenetic silencing of JAM3 promotes laryngeal squamous cell carcinoma development by inhibiting the Hippo pathway","volume":"53","author":"Jia","year":"2025","journal-title":"Oncology Reports"},{"issue":"10","key":"10.1016\/j.archoralbio.2026.106512_bib12","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a026831","article-title":"HDACs and HDAC inhibitors in cancer development and therapy","volume":"6","author":"Li","year":"2016","journal-title":"Cold Spring Harbor Perspectives in Medicine"},{"issue":"5","key":"10.1016\/j.archoralbio.2026.106512_bib13","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/s41419-020-2540-y","article-title":"LncRNA SOX2OT promotes temozolomide resistance by elevating SOX2 expression via ALKBH5-mediated epigenetic regulation in glioblastoma","volume":"11","author":"Liu","year":"2020","journal-title":"Cell Death Disease"},{"issue":"4","key":"10.1016\/j.archoralbio.2026.106512_bib14","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods (Sanoma Diego, California )"},{"key":"10.1016\/j.archoralbio.2026.106512_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fmmed.2024.1426454","article-title":"Role of epigenetic in cancer biology, in hematologic malignancies and in anticancer therapy","volume":"4","author":"Nwabo Kamdje","year":"2024","journal-title":"Frontiers in Molecular Medicine"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib16","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1186\/s13148-025-01933-w","article-title":"Multifaceted regulation of the HOX cluster and its implications in oral cancer","volume":"17","author":"Padam","year":"2025","journal-title":"Clinical Epigenetics"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-14412-6","article-title":"Identification of HOX signatures contributing to oral cancer phenotype","volume":"12","author":"Padam","year":"2022","journal-title":"Scientific Reports"},{"key":"10.1016\/j.archoralbio.2026.106512_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.771528","article-title":"Restoring HOXD10 exhibits therapeutic potential for ameliorating malignant progression and 5-fluorouracil resistance in colorectal cancer","volume":"11","author":"Pan","year":"2021","journal-title":"Frontiers in Oncology"},{"issue":"5","key":"10.1016\/j.archoralbio.2026.106512_bib19","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1136\/jcp.2003.007641","article-title":"Molecular biology of squamous cell carcinoma of the head and neck","volume":"59","author":"Perez-Ordo\u00f1ez","year":"2006","journal-title":"Journal of Clinical Pathology"},{"issue":"5","key":"10.1016\/j.archoralbio.2026.106512_bib20","doi-asserted-by":"crossref","DOI":"10.3390\/biom15050734","article-title":"Uncovering a novel role of ROR1 in the epigenetic regulation of tumor suppressor gene CREB3L1 in triple-negative breast cancer cells","volume":"15","author":"Reed","year":"2025","journal-title":"Biomolecules"},{"key":"10.1016\/j.archoralbio.2026.106512_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.archoralbio.2021.105195","article-title":"Homeobox gene amplification and methylation in oral squamous cell carcinoma","volume":"129","author":"Rodrigues","year":"2021","journal-title":"Archives of Oral Biology"},{"issue":"18","key":"10.1016\/j.archoralbio.2026.106512_bib22","doi-asserted-by":"crossref","first-page":"8803","DOI":"10.18632\/oncotarget.2492","article-title":"POU2F1 activity regulates HOXD10 and HOXD11 promoting a proliferative and invasive phenotype in head and neck cancer","volume":"5","author":"Sharpe","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/j.archoralbio.2026.106512_bib23","article-title":"Mechanisms and technologies in cancer epigenetics","volume":"14","author":"Sherif","year":"2024","journal-title":"Frontiers in Oncology"},{"issue":"15","key":"10.1016\/j.archoralbio.2026.106512_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/nar\/gks596","article-title":"Primer3-new capabilities and interfaces","volume":"40","author":"Untergasser","year":"2012","journal-title":"Nucleic Aci Research"},{"issue":"2","key":"10.1016\/j.archoralbio.2026.106512_bib25","doi-asserted-by":"crossref","DOI":"10.1093\/narcan\/zcaf020","article-title":"Discovery of epigenetically silenced tumour suppressor genes in aggressive breast cancer through a computational approach","volume":"7","author":"Vitte","year":"2025","journal-title":"NAR Cancer"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib26","first-page":"389","article-title":"Homeobox D10 gene, a candidate tumor suppressor, is downregulated through promoter hypermethylation and associated with gastric carcinogenesis","volume":"18","author":"Wang","year":"2012","journal-title":"Molecular Medicine (Cambridge, Mass )"},{"issue":"5","key":"10.1016\/j.archoralbio.2026.106512_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.gendis.2023.04.040","article-title":"Epigenetics: Mechanisms, potential roles, and therapeutic strategies in cancer progression","volume":"11","author":"Wang","year":"2024","journal-title":"Genes Diseases"},{"issue":"4","key":"10.1016\/j.archoralbio.2026.106512_bib28","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.3892\/or.2015.4194","article-title":"HOXD10 acts as a tumor-suppressive factor via inhibition of the RHOC\/AKT\/MAPK pathway in human cholangiocellular carcinoma","volume":"34","author":"Yang","year":"2015","journal-title":"Oncology Reports"},{"key":"10.1016\/j.archoralbio.2026.106512_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2024.102014","article-title":"The PRC2 complex epigenetically silences GATA4 to suppress cellular senescence and promote the progression of breast cancer","volume":"46","author":"Yu","year":"2024","journal-title":"Translational Oncology"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41420-024-01803-z","article-title":"Cancer epigenetics: From laboratory studies and clinical trials to precision medicine","volume":"10","author":"Yu","year":"2024","journal-title":"Cell Death Discovery"},{"issue":"1","key":"10.1016\/j.archoralbio.2026.106512_bib31","doi-asserted-by":"crossref","DOI":"10.1186\/s12964-018-0316-0","article-title":"Epigenetic inactivation of HOXD10 is associated with human colon cancer via inhibiting the RHOC\/AKT\/MAPK signaling pathway","volume":"17","author":"Yuan","year":"2019","journal-title":"Cell Communication and Signaling: CCS"}],"container-title":["Archives of Oral Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996926000166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0003996926000166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,20]],"date-time":"2026-03-20T01:30:24Z","timestamp":1773970224000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0003996926000166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,3]]},"references-count":31,"alternative-id":["S0003996926000166"],"URL":"https:\/\/doi.org\/10.1016\/j.archoralbio.2026.106512","relation":{},"ISSN":["0003-9969"],"issn-type":[{"value":"0003-9969","type":"print"}],"subject":[],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"HOXD10 expression in oral cancer is driven by histone acetylation rather than promoter DNA methylation","name":"articletitle","label":"Article Title"},{"value":"Archives of Oral Biology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.archoralbio.2026.106512","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"106512"}}